ProbioPure9: Nine Strains of Healthy Human Bacteria for Intestinal & Digestive Support

Why Take ProbioPure9 Probiotics?

By providing large numbers of these friendly bacteria to the intestinal tract they may increase the population of these bacteria compared to other less desirable strains. These strains may then competitively inhibit the growth of undesirable strains and also inhibit the production of toxic substances produced by less desirable strains.1 Further, studies suggest that they may stimulate our immune system to suppress the growth of pathogenic or undesired bacteria.2-4 Start feeling better, order your own ProbioPure9 Probiotics today!

[ probiopure9 probiotic home page ]

Are There Any Clinical Studies for Safety or Effectiveness For ProbioPure9 Probiotics?

A clinical study of 180 patients from eight different medical facilities in Japan noted significant improvement in patients with soft stools or diarrhea from taking a probiotic product containing Wakunaga's Lactobacillus acidophilus (L. acidophilus) and Bifidobacterium bifidum (B. bifidum).5 Regarding constipation, a clinical study of 39 patients showed improvement in 95% of the subjects after taking a multistrain product including Wakunaga's L. acidophilus and B. bifidum.2 Another clinical study using the same product showed improvement in 58 of 64 subjects with constipation.5 Abdominal distension improved in 63 of 66 subjects and frequency, hardness and odor improved. Clinical studies conducted on nearly 300 subjects revealed no side effects in subjects taking Wakunaga Probiotics.6,7

The probiotic strains used by Wakunaga have no toxicity based on basic toxicological and preclinical studies. Start feeling better, order your own ProbioPure9 Probiotics today!

[ probiopure9 probiotic home page ]

References

1. Yamashita, M., Fujisaki, M., Ohkushi, E., Kaihatsu, K. and Uchida, S. (1987)Clinics and Microorganisms 13(b): 87.
2. Honma, N., Ohtani, K. and Kikuchi, H. (1987) On effects of lactic acid bacteria. Part II. Clinical effects. New Medicines and Clinics 36(1): 75.
3. Honma, N. (1986) On effects of lactic acid bacteria. Part I. Biological significance New Medicines and Clinics 35(12): 2687-2695.
4. Honma, N. (1974) Intestinal bacteria flora of infants and infection protection. Pediatric Clinics 27(11): 20.
5. In-House Clinical Study Conducted on 180 Patients from 8 Different Medical Facilities (Kobe University and associated hospitals.)
6. Willard, T. (1989) Occurrence of diarrhea with the use of Kyo-Dophilus. Chiron Consultants Inc. Calgary, Canada.
7. Willard, T. 1989. Kyo-Dophilus use in the reduction of Candida albicans symptoms. Chiron Consultants Inc. Calgary, Canada.